An Improved and Scalable Process for Celecoxib: A Selective Cyclooxygenase-2 Inhibitor

被引：24
|
作者：
Reddy, Anumula Raghupathi [2 ]
Sampath, Alla [2 ]
Goverdhan, Gilla [2 ]
Yakambaram, Boja [2 ]
Mukkanti, Kagga [1 ,2 ]
Reddy, Padi Pratap [2 ]
机构：
[1] JNT Univ, Inst Sci & Technol, Ctr Environm Sci, Hyderabad 500072, Andhra Pradesh, India
[2] Dr Reddys Labs Ltd, Dept Res & Dev, Integrated Prod Dev, R R Dist 500072, AP, India
来源：
ORGANIC PROCESS RESEARCH & DEVELOPMENT | 2009年 / 13卷 / 01期
关键词：
COX-2; INHIBITORS; DERIVATIVES; PYRAZOLES; SC-58635;
D O I：
10.1021/op800158w
中图分类号：
O69 [应用化学];
学科分类号：
081704 ;
摘要：
An improved, scalable and commercially viable process is developed for an active pharmaceutical ingredient, celecoxib.
引用
收藏
页码：98 / 101
页数：4
相关论文
共 50 条
  • [41] Development of a predictive pharmacokinetic model for a novel cyclooxygenase-2 inhibitor
    Kastrissios, H
    Rohatagi, S
    Moberly, J
    Truitt, K
    Gao, Y
    Wada, R
    Takahashi, M
    Kawabata, K
    Salazar, D
    JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (05) : 537 - 548
  • [42] A Potent Cyclooxygenase-2 Inhibitor for Synthesized Pyrimidine and Thiazolopyrimidine Derivatives
    Amr, Abd El-Galil E.
    Al-Omar, Mohamed A.
    Abdalla, Mohamed M.
    INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2016, 12 (02) : 86 - 91
  • [43] Potent Cell Growth Inhibitory Effects in Hepatitis B Virus X Protein Positive Hepatocellular Carcinoma Cells by the Selective Cyclooxygenase-2 Inhibitor Celecoxib
    Xie, Huahong
    Gao, Liucun
    Chai, Na
    Song, Jiugang
    Wang, Jun
    Song, Zhenshun
    Chen, Caiping
    Pan, Yanglin
    Zhao, Lina
    Sun, Shiren
    Wu, Kaichun
    Feitelson, Mark A.
    Liu, Jie
    Fan, Daiming
    MOLECULAR CARCINOGENESIS, 2009, 48 (01) : 56 - 65
  • [44] Celecoxib, a selective cyclooxygenase-2 inhibitor, lowers plasma cholesterol and attenuates hepatic lipid peroxidation during carbon-tetrachloride-associated hepatotoxicity in rats
    Ekor, Martins
    Odewabi, Adesina O.
    Kale, Oluwafemi E.
    Adesanoye, Omolola A.
    Bamidele, Titilayo O.
    DRUG AND CHEMICAL TOXICOLOGY, 2013, 36 (01) : 1 - 8
  • [45] Prenatal effects of DuP-697 - the irreversible, highly selective cyclooxygenase-2 inhibitor
    Burdan, F
    Dudka, J
    Szumilo, J
    Korobowicz, A
    Klepacz, L
    REPRODUCTIVE TOXICOLOGY, 2003, 17 (04) : 413 - 419
  • [46] Suppression of intestinal polyp development by nimesulide, a selective cyclooxygenase-2 inhibitor, in Min mice
    Nakatsugi, S
    Fukutake, M
    Takahashi, M
    Fukuda, K
    Isoi, T
    Taniguchi, Y
    Sugimura, T
    Wakabayashi, K
    JAPANESE JOURNAL OF CANCER RESEARCH, 1997, 88 (12): : 1117 - 1120
  • [47] The effect of selective cyclooxygenase-2 inhibitor on human osteoclast precursors to influence osteoclastogenesis in vitro
    Kawashima, Masayuki
    Fujikawa, Yosuke
    Itonaga, Ichiro
    Takita, Chikahiro
    Tsumura, Hiroshi
    MODERN RHEUMATOLOGY, 2009, 19 (02) : 192 - 198
  • [48] Cyclooxygenase-2 selective inhibitor prevents implantation of eutopic endometrium to ectopic sites in rats
    Matsuzaki, S
    Canis, M
    Darcha, C
    Dallel, R
    Okamura, K
    Mage, G
    FERTILITY AND STERILITY, 2004, 82 (06) : 1609 - 1615
  • [49] Nephrotoxic potential of selective cyclooxygenase-2 inhibitors
    Sandhu, GK
    Heyneman, CA
    ANNALS OF PHARMACOTHERAPY, 2004, 38 (04) : 700 - 704
  • [50] Enhancement of photodynamic therapy by 2,5-dimethyl celecoxib, a non-cyclooxygenase-2 inhibitor analog of celecoxib
    Ferrario, Angela
    Lim, Sophia
    Xu, Frank
    Luna, Marian
    Gaffney, Kevin J.
    Petasis, Nicos A.
    Schoenthal, Axel H.
    Gomer, Charles J.
    CANCER LETTERS, 2011, 304 (01) : 33 - 40
12345